This website is intended for healthcare professionals

Thalassaemia

NHS to offer ‘life-changing’ gene-editing therapy for thalassaemia

Trials found that 93% of patients did not need blood transfusions after treatment, which has been described as a ‘historic moment’ for people with thalassaemia

NHS to offer stem cell transplants to patients living with rare blood disorder

The new treatment could cure adults living with thalassemia and help them avoid life-long blood transfusions

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP